Value
Agea Agea 69. 0 (66.0-72.0)
BMIa BMIa 25. 4 (23.5-27.6)
Genderb Female 61 (47.3%)
Male 68 (52.7%)
History of ESWLb Absent 100 (77.5%)
Present 29 (22.5%)
Metabolic Syndromeb Absent 88 (68.2%)
Present 41 (31.8%)
Stone Localizationb Lower pole 20 (15.5%)
Middle pole 5 (3.8%)
Upper pole 5 (3.8%)
Pelvis 46 (35.6%)
Proximal ureter 26 (20.1%)
Multiple calyxes 27 (20.9%)
Preoperative Hydronephrosisb None 45 (34.9%)
Grade 1 59 (45.7%)
Grade 2 22 (17.1%)
Grade 3 3 (2.3%)
Ureteral Wall Thicknessa (mm) Ureteral Wall Thicknessa (mm) 1.90 (1.7-2.4)
Preoperative Pelvis Urine Densitya (HU) Preoperative Pelvis Urine Densitya (HU) 7.0 (-4.0-9.0)
Stone Densitya (HU) Stone Densitya (HU) 1039. 0 (751.0-1223.0)
Stone Sizea (mm) Stone Sizea (mm) 90. 0 (80.0-130.0)
Postoperative stentb None 17 (13.2%)
Ureteral catheter 12 (9.3%)
Double-J stent 100 (77.5%)
Postoperative Complicationb None 121 (93.7%)
Fewer 7 (5.4%)
Perforation 0
Sepsis 1 (0.7%)
Death 0
Operation Timea (min) Operation Timea (min) 65. 0 (50.0-70.0)
Hospitalization Datea(day) Hospitalization Datea(day) 2. 0 (2.0-3.0)
Residual Fragmentb Absent 90 (69.7%)
Present 14 (10.8%)
CIRF 25 (18.6%)